top of page
Sean joined the Veprintsev lab in 2019 as part of the MRC IMPACT doctoral training program. His PhD project focuses on understanding the molecular basis for biased signalling in GPCRs by uncovering networks of amino acids connecting ligand and effector binding sites in the beta2-adrenoceptor.
Previously, Sean gained experience in ion channel pharmacology whilst studying his Master’s by Research at the University of East Anglia.
Sean Cullum: TeamMember
bottom of page